SS_B_Rx 6.19.17

SS_B_Rx 6.19.17.docx

Strategic Prevention Framework for Prescription Drugs (SPF-Rx)

OMB: 0930-0377

Document [docx]
Download: docx | pdf

Program Evaluation for Prevention Contract: Strategic Prevention Framework for Prescription Drugs

Supporting Statement



B. Collection of Information Employing Statistical Methods

B.1 Respondent Universe and Sampling Methods

Through the instruments at the center of this OMB application, the SPF-Rx data collection will use a census approach to collecting process and programmatic data.

Using a census approach, the targeted universe for the PEP-C SPF-Rx MRT is all SPF-Rx grantee PDs (N = 25) and grantee PDs from all future cohorts. As grantees have agreed to participate in cross-site evaluation data collection activities as a condition of funding, all 25 grantee PDs or other designated grantee staff are expected to complete the SPF-Rx cross-site instruments.

A census of all SPF-Rx grantee PDs is necessary as these data will be used by SAMHSA to monitor each program’s performance, and grantees will also use it to track their ongoing implementation. To meet its annual reporting requirements for GPRA and performance measures, SAMHSA must obtain data from all grantees, which supports the need for a census approach. In addition, the SPF-Rx program grantees have varying data available to them and are subject to varying laws and policies governing access to and use of PDMP data. The variety between the programs makes it critical to the SPF-Rx evaluation to capture the details of each program to be able to answer the EQs and assess which implementation characteristics are associated with better outcomes for particular types of communities.

While grantees will provide aggregated data into the cross-site evaluation tools, all outcomes data will come from existing archival data (e.g., state vital statistics, hospitalization and emergency department records).

B.2 Information Collection Procedures

Web-Based Instruments

With the exception of the SPF-Rx Grantee Interview, all of the instruments are all self-administered, web-based data collection tools completed through the MRT online data collection system. The SPF-Rx AII, Outcomes Module, and Substitute Data Source Request will be accessed through the MRT online data collection system.

Grantee PDs or their designated staff will complete all the instruments. The SPF-Rx AII, Outcomes Module, and Substitute Data Source Request will also be completed by subrecipient community PDs or their designees. Before data collection begins, each respondent will be provided a unique log-in to enter the data system, which will require the creation of a password. Respondent email addresses for each login will be stored within the system so that automatic alerts and notifications can be sent.

For SPF-Rx, the cross-site evaluation team will develop user manuals for accessing and navigating the online data collection systems and question-by-question and FAQ guides to help respondents accurately complete the instruments. Grantees and subrecipients will also be provided training webinars to walk through the online data collection system, review each instrument in detail, and go over data collection procedures. Within the online data collection systems, all manuals, guides, and training webinars will be archived and accessible to respondents for reference at any time. (The PEP‑C team developed these same types of materials for similar SAMHSA projects. See https://PEP‑C.rti.org/HERO/KB/PEP‑C-KB/Default.htm#PFS/PFS Overview.htm%3FTocPath%3DPartnerships%2520for%2520Success%2520(PFS)%7C_____0.)

Availability is important in any data collection system, especially one employed by grantee sites around the country in multiple time zones. The online systems will be maintained in an available state as much as possible to allow grantees to have access for entering data, as well as to give SAMHSA, grantees, and the SPF-Rx cross-site evaluation team access to reports.

The reporting system will be designed to be easy to use. The SPF-Rx evaluation team will implement user-friendly features across all functional areas, taking into account the needs of both SAMHSA and grantees. Additionally, every page of the SPF-Rx MRT online data system will have a Help or Support link, which will allow the respondent to access the following support resources:

1. Search the Knowledge Base. More comprehensive than a list of FAQs and more organized than a support forum, the Knowledge Base offers a layered information approach, so that respondents can search by keyword and then drill down to view material at increasing levels of detail. It will be a curated and easily searchable source of information including items such as

  • system documentation,

  • user guides,

  • policies and procedures,

  • protocols,

  • training materials, and

  • FAQs.

2. Contact Us. Respondents may request assistance by calling a provided toll-free number, sending an email request, or submitting a TA request form as desired. The toll-free line will be routed to an email system that is checked regularly by members of the T/TA team. Staff responding to TA requests will be trained in use of the system and have ready access to the full Knowledge Base. T/TA team staff will monitor all submitted tickets to ensure timely response and resolution of TA requests.

SPF-Rx Grantee Interview

The SPF-Rx cross-site evaluation team will also interview grantee PDs or their designated staff in the second, third, and final years of the grant, following the protocol outlined in Attachment 2. The SPF-Rx evaluation team will contact grantee PDs via email to set up interviews during regularly scheduled business hours. Before conducting the interview, the evaluation team will review grant applications (submitted to SAMHSA by each grantee and given to the evaluation team by SAMHSA) and other reporting data already provided by the grantee (e.g., progress monitoring reports). Relevant information will be abstracted to familiarize the interviewer with the grantee and avoid asking for any information that is already available. This will also reduce respondent burden.

Once the interview is scheduled, the contractor will provide the grantee PD or designated respondent with an electronic version of the assent form and an interview guide.

Before beginning the interview, consent will be requested to record the interview to confirm, if needed, the accuracy of noted responses. A senior evaluator from the contractor’s evaluation team will lead the respondent through the interview while a junior evaluator records responses and takes notes. After the interview, the interviewer will send an email thanking the respondent for his or her participation. The interviewer and notetaker will review the responses for accuracy. Any areas of discrepancy will be validated with the recording (if consented by the respondent). A copy of the notes will also be sent to the respondent for review. Any further comments by the respondent will be added to the notes. Once the responses are considered final, the recording will be deleted. An electronic version of the interview will be maintained on a password-protected, secure server accessible only to the contractor’s evaluation team.

This procedure will be followed for the follow-up data collection time points.

A procedures manual and the attached Grantee Interview protocol will be developed for the administration of the interview. Training on interview procedures and questions will be provided to all interviewers and notetakers. The training will be recorded and accessible for later viewing, if needed.

B.3 Methods to Maximize Response Rates

The terms and conditions of the grant awards require grantees to participate in all SPF-Rx cross-site evaluation data collection activities. The cross-site evaluation team will employ a number of strategies to help ensure that grantees participate with a 100% response rate.

As described above, the evaluation team will develop user manuals for accessing and navigating the MRT online data collection system and question-by-question and FAQ guides to help respondents accurately complete the online instruments. Grantees will also be provided with training webinars to walk through the MRT online data collection system and to review data collection procedures. Within the online data collection system, all manuals, guides, and training webinars will be archived and accessible to respondents for reference at any time.

SAMHSA Project Officers will monitor the MRT online data systems and receive email notifications when their grantees submit individual instruments such as Substitute Data Source Requests. Approximately 1 month after a data submission deadline, the PEP‑C team will provide Project Officers a list of past-due instruments. SAMHSA Project Officers will then follow up with their grantees to ensure submission. This system has already been successfully established and is running smoothly for related SAMHSA grants.

B.4 Test of Procedures

The Grantee Interview was pilot tested with four current SPF-Rx grantee PDs who are or were also PFS PDs. These interviews were conducted by telephone. Grantee and interviewer feedback from these interviews led to changes in the order of the questions to improve the flow of the interviews. The Grantee Interview is estimated to take 1.5 hours to complete; this includes 1.5 hours to complete the interview.

Five current SPF-Rx grantee PDs who are or were also PFS PDs completed the AII in word processing software. PEP‑C staff met with each grantee by telephone to discuss time of completion, questions about information in the instrument, and recommendations for improving the instrument. The AII is estimated to take 2.3 hours to complete; this includes 1.5 hours to look up and compile information and 0.8 hour to complete the web instrument.

Three current SPF-Rx grantee PDs who are or were also PFS PDs completed the Grantee-Level Outcomes Module, the Community-Level Outcomes Module, and the Substitute Data Source Request in word processing software. PEP‑C staff met with each grantee by telephone to discuss time of completion, questions about information in the instrument, and recommendations for improving the instrument. The Grantee-Level Outcomes Module is estimated to take 3 hours to complete; this includes 2 hour to look up and compile information and 1 hour to complete the web instrument. The Community-Level Outcomes Module is estimated to take 3 hours to complete; this includes 2 hours to look up and compile information and 1 hour to complete the web instrument. The Substitute Data Source Request instrument is estimated to take 1 hour to complete; this includes 0.5 hour to look up and compile information and 0.5 hour to complete the web instrument.

Each of the SPF-Rx grantees is a former SPF-PFS grantee; thus they will all have experience completing instruments similar in procedure (e.g., entering data into an online data system), length, and content. Additionally, the SPF-Rx performance measure data collection used lessons learned from the SPF-PFS evaluations to improve data collection procedures.

B.5 Statistical Consultants

The PEP‑C contractor team comprises several experts who will be directly involved in data collection and statistical analysis. Also, contractor in-house experts will be consulted throughout the program on various statistical aspects of the design, methodological issues, and data analysis. Finally, the PEP‑C project has an ESC whose members have already provided feedback on the cross-site evaluation design and instruments and will continue to provide advice and feedback through scheduled quarterly meetings and ad hoc emails as needed. Exhibit 9 provides details of these team members and advisors.

Exhibit 9: Statistical Consultants for the SPF-Rx Cross-Site Evaluation Through the Program Evaluation for Prevention Contract (PEP‑C)

Name & Role in Evaluation

Title & Address

Contact Information

PEP‑C Evaluation Staff

Elvira Elek, PhD

PEP‑C Deputy Director

Research Public Health Analyst

Public Health Policy Research

RTI International

701 13th Street, NW, Suite 750

Washington, DC 20005

Telephone: (202) 728–2048

Email: [email protected]

Phillip Graham, PhD

PEP‑C Project Director

Director

Drugs, Violence, and Delinquency Prevention Program

RTI International

3040 East Cornwallis Road

Research Triangle Park, NC 27709

Telephone: (919) 485–7752

Email: [email protected]

Gillian J. Leichtling

Senior Evaluator

Senior Research Associate

RMC Research Corporation

111 SW Columbia Street, Suite 1030 
Portland, OR 97201-5883

Telephone: (503) 223-8248 x735

Email: mailto:[email protected]

Monique Clinton-Sherrod, PhD

SPF-Rx Project Director

Director

Violence and Victimization Research Program

RTI International

3040 East Cornwallis Road

Research Triangle Park, NC 27709

Telephone (919) 597-5103

Email: [email protected]

Cheryl Roberts, PhD

SPF-Rx Deputy Project Director

Research Sociologist

Drugs, Violence, and Delinquency Prevention Program

RTI International

3040 East Cornwallis Road

Research Triangle Park, NC 27709

Telephone (919) 541-7251

Email: [email protected]

Jason Williams, PhD

PEP‑C SPF-Rx Analysis Team Leader

Senior Research Quantitative Psychologist

Risk Behavior and Family Research

RTI International

3040 East Cornwallis Road

Research Triangle Park, NC 27709

Telephone: (919) 541-6734

Email: [email protected]

Antonio Morgan-Lopez, PhD

PEP‑C Analysis Team Leader

Senior Research Quantitative Psychologist

Risk Behavior and Family Research

RTI International

3040 East Cornwallis Road

Research Triangle Park, NC 27709

Telephone: (919) 316-3436

Email: [email protected]

Nick Peiper

Research Public Health Analyst

Behavioral and Urban Health Program

RTI International

3040 East Cornwallis Road

Research Triangle Park, NC 27709

Telephone: (919) 316-3314

Email: [email protected]

Steve Sullivan

ESC Task Team Leader

Senior Director

Cloudburst Consulting Group, Inc.

8400 Corporate Drive, Suite 550

Landover, MD 20785-2238

Telephone: (301) 918-4400

Email: msteven.sullivan@cloudburstgroup.
com

Government Project Officers

Thomas Clarke, PhD

Contracting Officer’s Representative

Social Science Analyst

Performance and Technical Assistance Branch

Division of Systems Development

SAMHSA/CSAP

5600 Fishers Lane, Room 16E07

Rockville, MD 20867

Telephone: (240) 276-0493

Email: [email protected]

Anthony Johnson

Alternate Contracting Officer’s Representative

Senior Public Health Analyst

Program Management Officer

Performance and Technical Assistance Branch

Division of Systems Development

SAMHSA/CSAP

5600 Fishers Lane, Room 16E01B

Rockville, MD 20857

Telephone: (240) 276-0135

Email: [email protected]

Sandra Adrovet

Contracting Officer’s Representative

Public Health Advisor

East Team

SAMHSA/CSAP

1 Choke Cherry Road, Room 4-1048
Rockville, MD 20857

Telephone: (240) 276-1489

Email: [email protected]

Kim Nesbitt

Contracting Officer’s Representative

Public Health Advisor

West Team

SAMHSA/CSAP

5600 Fishers Lane, Room 16E65A

Rockville, MD 20857

Telephone: 240-276-1742

Email: [email protected]

Tonia Gray

Contracting Officer’s Representative

Senior Public Health Advisor

West Team Lead

Division of State Programs

SAMHSA/CSAP

5600 Fishers Lane, Room 16E25B

Rockville, MD 20857

Telephone: (240) 276-2492

Email: [email protected]

Stephanie Blake


Social Science Analyst

Division of Systems Development

SAMHSA/CSAP

5600 Fishers Lane, Room 16E09C

Rockville, MD 20857

Telephone: (240) 276-1623

Email: [email protected]

External Steering Committee

Bethany Bray, PhD

Methods/Statistics

Research Associate

The Methodology Center

The Pennsylvania State University

400 Calder Square II

State College, PA 16801

Telephone: (814) 865-1225

Email: [email protected]

William DeJong, PhD

Evaluating Environmental Strategies

Professor

Boston University School of Public Health

Community Health Sciences

801 Mass Ave Crosstown Center

Boston, MA 02118

Telephone: (508) 954-0224

Email: [email protected]

Brian Flay, DrPH

Prevention Science

Professor

Oregon State University

College of Public Health and Human Sciences

457 Waldo Hall

Corvallis, OR 9733

Telephone: (541) 737-3837

Email: [email protected]

Chris Ringwalt, DrPH

Instrument Design; Intervention Implementation and Dissemination

Public Health Senior Research Scientist

Pacific Institute for Research and Evaluation

1516 East Franklin Street, Suite 200

Chapel Hill, NC 27514-2812

Telephone: (919) 259-0643

Email: [email protected]

Brenda Rowe

FDA Program Director

Alcohol and Tobacco Division

GA Department of Revenue

1800 Century Center Boulevard,
Suite 400

Atlanta, GA 30345

Telephone: (404) 417-4234

Email: [email protected]



LIST OF ATTACHMENTS


  1. Annual Implementation Instrument

  2. Grantee Interview

  3. Grantee-Level Outcomes Module

  4. Community-Level Outcomes Module

  5. Substitute Data Source Request

  6. SPF-Rx Evaluation Plan Checklist


5


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorTom Clarke
File Modified0000-00-00
File Created2021-01-22

© 2024 OMB.report | Privacy Policy